MOH PE Ratio & Valuation,Is MOH Overvalued

MOH Relative Valuation

MOH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MOH is overvalued; if below, it's undervalued.

Historical Valuation

Molina Healthcare Inc (MOH) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.50 is considered Undervalued compared with the five-year average of 15.05. The fair price of Molina Healthcare Inc (MOH) is between 176.43 to 223.67 according to relative valuation methord. Compared to the current price of 166.50 USD , Molina Healthcare Inc is Undervalued By 5.63%.

Relative Value

Fair Zone

176.43-223.67

Current Price：166.50

5.63%

Undervalued

14.50

7.71

EV/EBITDA

Molina Healthcare Inc. (MOH) has a current EV/EBITDA of 7.71. The 5-year average EV/EBITDA is 8.80. The thresholds are as follows: Strongly Undervalued below 5.79, Undervalued between 5.79 and 7.30, Fairly Valued between 10.31 and 7.30, Overvalued between 10.31 and 11.82, and Strongly Overvalued above 11.82. The current Forward EV/EBITDA of 7.71 falls within the Historic Trend Line -Fairly Valued range.

8.74

EV/EBIT

Molina Healthcare Inc. (MOH) has a current EV/EBIT of 8.74. The 5-year average EV/EBIT is 9.66. The thresholds are as follows: Strongly Undervalued below 6.29, Undervalued between 6.29 and 7.97, Fairly Valued between 11.34 and 7.97, Overvalued between 11.34 and 13.03, and Strongly Overvalued above 13.03. The current Forward EV/EBIT of 8.74 falls within the Historic Trend Line -Fairly Valued range.

0.19

Molina Healthcare Inc. (MOH) has a current PS of 0.19. The 5-year average PS is 0.49. The thresholds are as follows: Strongly Undervalued below 0.26, Undervalued between 0.26 and 0.37, Fairly Valued between 0.60 and 0.37, Overvalued between 0.60 and 0.72, and Strongly Overvalued above 0.72. The current Forward PS of 0.19 falls within the Strongly Undervalued range.

20.27

P/OCF

Molina Healthcare Inc. (MOH) has a current P/OCF of 20.27. The 5-year average P/OCF is 12.37. The thresholds are as follows: Strongly Undervalued below 5.00, Undervalued between 5.00 and 8.68, Fairly Valued between 16.05 and 8.68, Overvalued between 16.05 and 19.73, and Strongly Overvalued above 19.73. The current Forward P/OCF of 20.27 falls within the Strongly Overvalued range.

14.31

P/FCF

Molina Healthcare Inc. (MOH) has a current P/FCF of 14.31. The 5-year average P/FCF is 12.85. The thresholds are as follows: Strongly Undervalued below 7.23, Undervalued between 7.23 and 10.04, Fairly Valued between 15.66 and 10.04, Overvalued between 15.66 and 18.47, and Strongly Overvalued above 18.47. The current Forward P/FCF of 14.31 falls within the Historic Trend Line -Fairly Valued range.

Molina Healthcare Inc (MOH) has a current Price-to-Book (P/B) ratio of 2.03. Compared to its 3-year average P/B ratio of 4.24 , the current P/B ratio is approximately -52.26% higher. Relative to its 5-year average P/B ratio of 5.18, the current P/B ratio is about -60.91% higher. Molina Healthcare Inc (MOH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 3.91%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 7.23% , the current FCF yield is about -100.00% lower.

2.03

P/B

Median3y

4.24

Median5y

5.18

-6.63

FCF Yield

Median3y

3.91

Median5y

7.23

Competitors Valuation Multiple

The average P/S ratio for MOH's competitors is , providing a benchmark for relative valuation. Molina Healthcare Inc Corp (MOH) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 11.00%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of MOH decreased by 42.79% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 8.25 to 10.25.

The secondary factor is the Revenue Growth, contributed 11.00%to the performance.

Overall, the performance of MOH in the past 1 year is driven by P/E Change. Which is more unsustainable.

11.00%

10.34B → 11.48B

Revenue Growth

-78.10%

3.15 → 0.69

Margin Expansion

24.31%

8.25 → 10.25

P/E Change

-42.79%

291.05 → 166.50

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Molina Healthcare Inc (MOH) currently overvalued or undervalued?

What is Molina Healthcare Inc (MOH) fair value?

MOH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Molina Healthcare Inc (MOH) is between 176.43 to 223.67 according to relative valuation methord.

How does MOH's valuation metrics compare to the industry average?

What is the current P/B ratio for Molina Healthcare Inc (MOH) as of Dec 16 2025?

As of Dec 16 2025, Molina Healthcare Inc (MOH) has a P/B ratio of 2.03. This indicates that the market values MOH at 2.03 times its book value.

What is the current FCF Yield for Molina Healthcare Inc (MOH) as of Dec 16 2025?

As of Dec 16 2025, Molina Healthcare Inc (MOH) has a FCF Yield of 0.00%. This means that for every dollar of Molina Healthcare Inc’s market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Molina Healthcare Inc (MOH) as of Dec 16 2025?

As of Dec 16 2025, Molina Healthcare Inc (MOH) has a Forward P/E ratio of 14.50. This means the market is willing to pay $14.50 for every dollar of Molina Healthcare Inc’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Molina Healthcare Inc (MOH) as of Dec 16 2025?

As of Dec 16 2025, Molina Healthcare Inc (MOH) has a Forward P/S ratio of 0.00. This means the market is valuing MOH at $0.00 for every dollar of expected revenue over the next 12 months.

MOH Valuation